; and (2) provides appropriate contact information for SARS–CoV–2 testing sites pursuant to paragraph (1). 546. Reporting of COVID–19 testing results (a) In general Every laboratory that performs or analyzes a test that is intended to detect SARS–CoV–2 or to diagnose a possible case of COVID–19 shall report daily the number of tests performed and the results from each such test to the Secretary of Health and Human Services and to the Secretary of Homeland Security, in such form and manner as such Secretaries may prescribe. Such information shall be made available to the public in a searchable, electronic format as soon as is practicable, and in no case later than one week after such information is received. (b) Additional reporting requirements The Secretaries specified in subsection (a)— (1) may specify additional reporting requirements under this section by regulation, including by interim final rule, or by guidance; and (2) may issue such regulations or guidance without regard to the procedures otherwise required by section 553 of title 5, United States Code. 547. GAO report on diagnostic tests (a) GAO study Not later than 18 months after the date of enactment of this Act, the Comptroller General of the United States shall submit to the Committee on Energy and Commerce of the House of Representatives and the Committee on Health, Education, Labor and Pensions of the Senate a report describing the response of entities described in subsection (b) to the COVID–19 pandemic with respect to the development, regulatory evaluation, and deployment of diagnostic tests. (b) Entities described Entities described in this subsection include— (1) laboratories, including public health, academic, clinical, and commercial laboratories; (2) diagnostic test manufacturers; (3) State, local, Tribal, and territorial governments